Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $1.46, but opened at $1.33. Akso Health Group shares last traded at $1.4150, with a volume of 3,774 shares traded.
Analysts Set New Price Targets
Several research analysts have commented on AHG shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Akso Health Group in a research report on Monday, April 20th. Wall Street Zen raised Akso Health Group to a “sell” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Akso Health Group currently has a consensus rating of “Sell”.
Get Our Latest Stock Report on AHG
Akso Health Group Stock Up 4.9%
Institutional Trading of Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC purchased a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is currently owned by institutional investors.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Recommended Stories
- Five stocks we like better than Akso Health Group
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
